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Substandard antimalarial drugs are a major problem to the health of citizens in
developing countries, and it is likely that the problem persists due to the lack of
means to detect substandard drugs. Various colorimetric techniques have been
implemented to determine if a drug contains the stated active ingredient or not, but
vibrational spectroscopies such as NIR and Raman can be used to more reliably
quantify the amount of active ingredient. The use of Raman, however, has been
limited by the presence of significant sample fluorescence that interferes with
detection of the SERS signals of the active ingredients. Thus, we have started testing
the ability of Surface-Enhanced Raman Spectroscopy (SERS) to detect and quantify
ten common antimalarial drugs. We found that unique spectra for each of the
compounds were able to be taken, and therefore SERS can be used to determine the
active ingredient of many antimalarial drugs. To determine the quantification ability
of SERS, two Partial Least Squares (PLS) based quantifiers were developed for drugs
containing both of the active ingredients Artemether and Lumefantrine, the first of
which attempted to predict the relative amounts of the two active ingredients at a
concentration near the standard value, and the second, which attempted to predict
the absolute amount of active ingredient given that the ratio between the two active
ingredients was very close to the standard amount. The main objective of this
research is to find out and show the possibility of using SERS in detecting and
quantifying the amount of expected active ingredients in the antimalarial drugs that
are available in markets of some developed and developing countries.

